Cherouvim Ep

Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open Treatment

E. Zintzaras, H. Moutsopoulos, M. Manoussakis, 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.